Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf105 | FIMM | pan-cancer | AAC | 0.53 | 0.002 |
mRNA | HNRNPH1 | FIMM | pan-cancer | AAC | 0.54 | 0.001 |
mRNA | ALK | GDSC1000 | pan-cancer | AAC | 0.54 | 2e-28 |
mRNA | PFDN4 | FIMM | pan-cancer | AAC | 0.55 | 0.0008 |
mRNA | TDRD1 | FIMM | pan-cancer | AAC | 0.55 | 0.001 |
mRNA | PPP1R12A | FIMM | pan-cancer | AAC | 0.56 | 0.002 |
mRNA | KIAA1033 | FIMM | pan-cancer | AAC | 0.56 | 0.002 |
mRNA | SPTLC1 | FIMM | pan-cancer | AAC | 0.57 | 0.001 |
mRNA | MLLT10 | FIMM | pan-cancer | AAC | 0.57 | 0.001 |
mRNA | TRMO | FIMM | pan-cancer | AAC | 0.57 | 0.0006 |